$MLGC ML Capital Group, Inc. Retained by PrimaPharm
ML Capital Group, Inc. Retained by PrimaPharm
FOUNTAIN HILLS, AZ--(Marketwired - Nov 19, 2013) - ML Capital Group, Inc. (OTCQB: MLCG) is pleased to announce that it has been retained by a new client, PrimaPharm, Inc. (PPI) for marketing, business development and corporate advisory services.
PrimaPharm, Inc., based in San Diego, CA, is a contract manufacturer of drugs, devices, cosmetics and diagnostic products. PrimaPharm has been in business since 1992 and is an ISO 13485 certified (BSI) and FDA (Drug & Device) inspected facility and has full manufacturing capabilities in over 20,000 square feet including class 10,000 and class 100 clean room facilities. PrimaPharm's management team has over 100 years combined experience in the manufacture and development of products for regulated industries worldwide, which includes injectable drugs, aseptic lyophilization, isolation of natural and biological products including enzymes, proteins and peptides. PPI customers have included major pharmaceutical companies as well as many "start-ups" and small to medium companies engaged in product and process development. PrimaPharm is compliant with the FDA's principles and guidelines of Good Manufacturing Practices (cGMP's) and is QSR and ISO certified.
Mrs. Nelson, ML Capital Group's President, stated, "PrimaPharm is an amazing company that produces a wide range of regulated products and upholds the highest standards in manufacturing and business best practices, in addition to promoting 'Made In The USA' which we deeply appreciate and respect. It's an honor to work with such a great company and we look forward to helping them attain their next level of business growth and expansion."
ML Capital Group, Inc. has been retained by PPI to assist with various growth oriented initiatives relative to marketing, human resources management, and general corporate advisory services. The term of the Company's engagement with PrimaPharm is for a period of six months and may be extended by the mutual consent of both parties. "PrimaPharm selected ML Capital Group due to the diversity of its team and ability to assist us with several growth initiatives that we're focusing on right now. They understand our objectives and we're excited about what the future holds for us in working with each other," stated Mark Livingston, PrimaPharm's President and CEO.
ML Capital Group's stock is traded on the OTC Bulletin Board and OTC Markets where it is qualified to be listed in the QB marketplace as a current reporting company. You can access the Company's stock quote directly from OTC Markets at www.otcmarkets.com/stock/MLCG/quote. To find out more information on the Company, visit its website at www.mlcapitalgroupinc.com.
About ML Capital Group, Inc.:
ML Capital Group, Inc.'s primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth. The Company helps clients to build effective personnel teams, enhance their sales and marketing strategies, streamline their operations and maximize their profitability.
Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Investor Relations Contact:
Lisa Nelson
President & CEO
ML Capital Group, Inc.
Phone: 480-816-5308
Email: lisa@mlcapitalgroupinc.com
ML Capital Group, Inc. Retained by PrimaPharm
FOUNTAIN HILLS, AZ--(Marketwired - Nov 19, 2013) - ML Capital Group, Inc. (OTCQB: MLCG) is pleased to announce that it has been retained by a new client, PrimaPharm, Inc. (PPI) for marketing, business development and corporate advisory services.
PrimaPharm, Inc., based in San Diego, CA, is a contract manufacturer of drugs, devices, cosmetics and diagnostic products. PrimaPharm has been in business since 1992 and is an ISO 13485 certified (BSI) and FDA (Drug & Device) inspected facility and has full manufacturing capabilities in over 20,000 square feet including class 10,000 and class 100 clean room facilities. PrimaPharm's management team has over 100 years combined experience in the manufacture and development of products for regulated industries worldwide, which includes injectable drugs, aseptic lyophilization, isolation of natural and biological products including enzymes, proteins and peptides. PPI customers have included major pharmaceutical companies as well as many "start-ups" and small to medium companies engaged in product and process development. PrimaPharm is compliant with the FDA's principles and guidelines of Good Manufacturing Practices (cGMP's) and is QSR and ISO certified.
Mrs. Nelson, ML Capital Group's President, stated, "PrimaPharm is an amazing company that produces a wide range of regulated products and upholds the highest standards in manufacturing and business best practices, in addition to promoting 'Made In The USA' which we deeply appreciate and respect. It's an honor to work with such a great company and we look forward to helping them attain their next level of business growth and expansion."
ML Capital Group, Inc. has been retained by PPI to assist with various growth oriented initiatives relative to marketing, human resources management, and general corporate advisory services. The term of the Company's engagement with PrimaPharm is for a period of six months and may be extended by the mutual consent of both parties. "PrimaPharm selected ML Capital Group due to the diversity of its team and ability to assist us with several growth initiatives that we're focusing on right now. They understand our objectives and we're excited about what the future holds for us in working with each other," stated Mark Livingston, PrimaPharm's President and CEO.
ML Capital Group's stock is traded on the OTC Bulletin Board and OTC Markets where it is qualified to be listed in the QB marketplace as a current reporting company. You can access the Company's stock quote directly from OTC Markets at www.otcmarkets.com/stock/MLCG/quote. To find out more information on the Company, visit its website at www.mlcapitalgroupinc.com.
About ML Capital Group, Inc.:
ML Capital Group, Inc.'s primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth. The Company helps clients to build effective personnel teams, enhance their sales and marketing strategies, streamline their operations and maximize their profitability.
Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Investor Relations Contact:
Lisa Nelson
President & CEO
ML Capital Group, Inc.
Phone: 480-816-5308
Email: lisa@mlcapitalgroupinc.com
